MARCH 16, 2020
KnowIT 2020
Quick Links

Knox Law
Intellectual Property Legal News
In house attorneys looking for a better way to organize, vet and easily retrieve legal news created the National Law Review on-line edition.

Around the clock, the National Law Review's editors screen and classify breaking news and analysis authored by recognized legal professionals and our own journalists.

There is no log in to access the database and new articles are added hourly.
Schwegman, Lundberg, Woessner LogoThe China National Intellectual Property Administration (CNIPA) has released patent statistics for combined January and February 2020 showing a 9% decline in invention patent application filings compared to the first two months of 2019.  2019 as a whole had already shown a significant decrease in filings. Combined January/February data is often used due to variation in the timing of the Lunar New Year holiday, which can occur in January or February and cause a tremendous decrease in patent filings due to holiday closures. More on Chinese Coronavirus Patent Office Statistics Here>
International arbitration is becoming an increasingly relevant forum for the resolution of intellectual property (“IP”) disputes. This should not be a surprise given multi-country licensing of patents, trademarks and trade secrets, as well as broader market forces such as globalization, digitalization, and the Internet. In a global economy, intellectual property rights (“IPRs”) are often a company’s most valuable assets. The ability to exploit, protect and enforce IPRs on a cross-border level is thus critical. As with other types of cross-border disputes, international arbitration provides an attractive forum for the resolution of disputes over IPRs. More on International Arbitration in IP Here >
Squire Patton Boggs Law Firm LogoIn March, we celebrate Women’s History Month and International Women’s Day, acknowledging the role of women in American history and the achievements of women worldwide. In the world of intellectual property (IP), we remember those who invented frequency hopping spread-spectrum signaling, kevlar, center-track restraint systems for animals, and the paper bag, among other things. We also acknowledge that there is substantial room for improvement in the patenting of inventions by women. More on Women Inventors and Women in IP Here>
Between 2005 and 2015, 78% of drugs associated with new patents were not new drugs. The practice of obtaining patents covering these “new inventions,” which include modifications of known drugs or new mixtures or delivery methods of known drugs, is commonly referred to as evergreening, and has become one of many tactics drug makers use to shield a product’s market exclusivity long past the product’s initial patent term and delay the entry of generic competition2 into the market. Recent moves by legislators to increase generic competition, and thereby reduce drug prices, have inspired drug makers to explore other ways to use patents to protect their investment in blockbuster brand-name products. In the case of at least one particular drug therapy, this has meant evergreening to the extreme.  More on Zeppelin Litigation Here >
Please let other interested professionals know about this valuable and free resource!

If you know someone interested in publishing with the National Law Review, kindly contact us at:
The National Law Review
National Law Forum, LLC
Jennifer Schaller, Esq.
NLR Publication Areas
The National Law Review
 708-357-3317 | jschaller@natlawreview.com | www.natlawreview.com
4700 Gilbert Avenue Suite #47 #230
Western Springs, IL 60558